These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17047444)

  • 1. Plasma asymmetric dimethylarginine level and extent of lesion at coronary angiography.
    Sahinarslan A; Cengel A; Biberoglu G; Hasanoglu A; Turkoglu S; Timurkaynak T
    Coron Artery Dis; 2006 Nov; 17(7):605-9. PubMed ID: 17047444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease.
    Lu TM; Ding YA; Charng MJ; Lin SJ
    Clin Cardiol; 2003 Oct; 26(10):458-64. PubMed ID: 14579916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric dimethylarginine and coronary collateral vessel development.
    Kocaman SA; Sahinarslan A; Biberoglu G; Hasanoglu A; Akyel A; Timurkaynak T; Cengel A
    Coron Artery Dis; 2008 Nov; 19(7):469-74. PubMed ID: 18923242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between plasma asymmetrical dimethylarginine and coronary artery disease].
    Song Y; Qu XF; Yu YW; Luan TZ; Li JJ; Guo H; Yu Y
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1527-30. PubMed ID: 17785101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
    Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A
    Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of plasma asymmetric dimethylarginine (ADMA) level and L-arginine/ADMA ratio on the development of coronary collaterals].
    Selçuk MT; Selçuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Duru E; Saşmaz A
    Turk Kardiyol Dern Ars; 2008 Apr; 36(3):150-5. PubMed ID: 18626206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study.
    Kruszelnicka O; Surdacki A; Golay A
    Cardiovasc Diabetol; 2013 Oct; 12():145. PubMed ID: 24103320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between brachial-ankle pulse wave velocity and the ratio of l-arginine to asymmetric dimethylarginine in patients undergoing coronary angiography.
    Masaki N; Hakuno D; Toya T; Shiraishi Y; Kujiraoka T; Namba T; Yada H; Kimura K; Miyazaki K; Adachi T
    J Cardiol; 2015 Apr; 65(4):311-7. PubMed ID: 25043133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between L-arginine/asymmetric dimethylarginine, homocysteine, folic acid, vitamin B levels, and coronary artery ectasia.
    Koc F; Ardic I; Erdem S; Kalay N; Ozbek K; Yarlioglues M; Ceyhan K; Celik A; Kadi H; Taner A; Sahin S; Onalan O; Kaya MG
    Coron Artery Dis; 2010 Dec; 21(8):445-9. PubMed ID: 20861735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma asymmetric dimethylarginine and L-arginine levels in patients with cardiac syndrome X.
    Okyay K; Cengel A; Sahinarslan A; Tavil Y; Turkoglu S; Biberoglu G; Hasanoglu A
    Coron Artery Dis; 2007 Nov; 18(7):539-44. PubMed ID: 17925607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of asymmetric dimethylarginine gradients across high-grade lesions in patients with coronary artery disease.
    Joyal D; Leya F; Obada Al-Chekakie M; Arab D; Dieter RS; Morshedi-Meibodi A; Lewis B; Steen L; Fareed J; Hoppenstead D; Akar JG
    Coron Artery Dis; 2007 Sep; 18(6):471-5. PubMed ID: 17700219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relation of asymmetric dimethylarginine levels with conventional risk score systems in the healthy subjects with positive family history for coronary artery disease].
    Satılmışoğlu H; Ozhan H; Albayrak S; Kaya A; Erden I; Yazıcı M
    Anadolu Kardiyol Derg; 2011 Mar; 11(2):114-8. PubMed ID: 21285018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine.
    Thum T; Tsikas D; Stein S; Schultheiss M; Eigenthaler M; Anker SD; Poole-Wilson PA; Ertl G; Bauersachs J
    J Am Coll Cardiol; 2005 Nov; 46(9):1693-701. PubMed ID: 16256870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric dimethylarginine predicts impaired epicardial coronary vasomotion in patients with angina in the absence of obstructive coronary artery disease.
    Parikh RV; Pargaonkar V; Ball RL; Kobayashi Y; Kimura T; Yeung AC; Cooke JP; Tremmel JA
    Int J Cardiol; 2020 Jan; 299():7-11. PubMed ID: 31416658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment.
    Bae SW; Stühlinger MC; Yoo HS; Yu KH; Park HK; Choi BY; Lee YS; Pachinger O; Choi YH; Lee SH; Park JE
    Am J Cardiol; 2005 Mar; 95(6):729-33. PubMed ID: 15757598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of asymmetric dimethylarginine (ADMA) with extent and functional severity of coronary atherosclerosis.
    Mangiacapra F; Conte M; Demartini C; Muller O; Delrue L; Dierickx K; Di Sciascio G; Trimarco B; De Bruyne B; Wijns W; Bartunek J; Barbato E
    Int J Cardiol; 2016 Oct; 220():629-33. PubMed ID: 27391005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events.
    Krempl TK; Maas R; Sydow K; Meinertz T; Böger RH; Kähler J
    Eur Heart J; 2005 Sep; 26(18):1846-51. PubMed ID: 15860520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, and risk of coronary artery disease: A meta-analysis based on 4713 participants.
    Xuan C; Tian QW; Li H; Zhang BB; He GW; Lun LM
    Eur J Prev Cardiol; 2016 Mar; 23(5):502-10. PubMed ID: 25956428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric dimethylarginine levels in patients with coronary artery ectasia.
    Cay S; Cagirci G; Akcay M; Karakurt O; Kahraman E; Yazihan N; Canga A; Akdemir R; Aydogdu S
    Kardiol Pol; 2009 Dec; 67(12):1362-8. PubMed ID: 20054767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-type natriuretic peptide and extent of lesion on coronary angiography in stable coronary artery disease.
    Sahinarslan A; Cengel A; Okyay K; Yazici HU; Elbey S; Cemri M; Ozdemir M; Timurkaynak T
    Coron Artery Dis; 2005 Jun; 16(4):225-9. PubMed ID: 15915074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.